2nd Quarter - Report

PREMIER, INC. for PREMIER, INC.

Firm
Client
Income
—
Expenses
$370,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

American Health Care Act (AHCA), H.R. 1628 Prescription Drug Price Transparency Act, H.R. 1316 PHA section, 21st Century Cures Act (Public Law: 114-255): Home infusion provisions (section 5004, section 5012) Improving Transparency and Accuracy in Medicare Part D Spending Act, H.R. 1038/S.413 Pharmacy and Medically Underserved Areas, H.R.592/S.109 Ensuring Seniors Access to Local Pharmacies Act of 2017, H.R.1939 FAST Generics Act of 2017, H.R.2051 CREATES Act of 2017, H.R.2212/S.974 ACCESS Act of 2017, H.R. 1704 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017 Making Pharmaceutical Markets More Competitive Act, H.R.2562/S.1115 Increasing Competition in Pharmaceuticals Act, H.R.297 Protecting Access to Care, H.R.1215 Preserve Access to Affordable Generics Act, S.124 Protecting Seniors' Access to Medicare Act of 2017, H.R.847/S.260

LobbyistCovered position, as disclosed
BLAIR GORDON CHILDS —
DUANNE PEARSON —
MARGARET REAGAN —
SHARA SIEGEL New —

Contacted: SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2212 (115th), S. 413 (115th), H.R. 592 (115th), H.R. 297 (115th), S. 109 (115th), H.R. 1316 (115th), H.R. 1038 (115th), H.R. 1704 (115th), S. 1115 (115th), H.R. 1628 (115th), H.R. 1939 (115th), H.R. 1215 (115th), S. 260 (115th), S. 974 (115th), H.R. 2051 (115th), H.R. 2562 (115th), S. 124 (115th), H.R. 847 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.